⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

Ledande inom antikroppsbaserad behandling mot IL1RAP

Ledande inom antikroppsbaserad behandling mot IL1RAP

Unclaimed

AEO Score: 4/10

Crawled 1 times by AI engines

Claude

cantargia.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Ledande inom antikroppsbaserad behandling mot IL1RAP just got measured.

4/10 means Ledande inom antikroppsbaserad behandling mot IL1RAP is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About Ledande inom antikroppsbaserad behandling mot IL1RAP

Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för behandling av såväl cancer som autoimmuna och inflammatoriska sjukdomar.

Key Topics

Vi utvecklar antikroppsbaserade läkemedel riktade mot IL1RAP
Vårt mål är att behandla cancer samt autoimmuna och inflammatoriska sjukdomar
Starka resultat ger stöd åt våra utvecklingsprojekt

Details

Industry: Technology

cantargia.com

AI Visibility Breakdown

1

Structured Data

6

Content Structure

5

Entity Clarity

3

E-E-A-T Signals

6

Technical AEO

2

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for Ledande inom antikroppsbaserad behandling mot IL1RAP: Tech & Electronics

Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?

Tech buyers are the most research-intensive shoppers on the internet.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Ledande inom antikroppsbaserad behandling mot IL1RAP.

Source & Attribution

Scored by Engagemii on July 1, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/cantargia

Cite this score: Engagemii (2026). "AEO Score for Ledande inom antikroppsbaserad behandling mot IL1RAP." Retrieved from https://engagemii.com/aeo/brands/cantargia

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform